Device At - Fixed Interventional X-Ray/Angiography Fluoroscopy

Artis Icono Biplane

Payments companies reported to CMS as associated with Artis Icono Biplane. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$104Kassociated payments (2023-2025)
466clinicians with associated payments
1company reporting

By year

2023 $42K
2024 $40K
2025 $22K

Payments reported as associated with Artis Icono Biplane, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular & Interventional Radiology $32K
Diagnostic Radiology $19K
Neurological Surgery $7,261
Cardiovascular Disease $6,208
Neuroradiology $5,451
Neurology (Psychiatry & Neurology) $5,038

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Artis Icono Biplane

These are the largest totals companies reported as associated with Artis Icono Biplane. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Alexander Misono Newport Beach, CA Vascular & Interventional Radiology $8,016.52
Orlando Diaz Houston, TX Vascular & Interventional Radiology $2,457.49
Suryakumar Reddy Wichita, KS Vascular & Interventional Radiology $2,245.32
M Ziad Darkhabani Green Bay, WI Vascular Neurology $2,126.44
Faheem Sheriff El Paso, TX Neurocritical Care $1,892.02
Naomi Gedion Los Angeles, CA Registered Nurse $1,834.33
James Hui Malibu, CA Diagnostic Radiology $1,498.08
Chih-Sheng Chiang Los Angeles, CA Vascular & Interventional Radiology $1,470.17
Satya Patro Little Rock, AR Diagnostic Radiology $1,258.40
Ioannis Chatzizisis Coral Gables, FL Cardiovascular Disease $1,251.64

Prescribed Artis Icono Biplane?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.